OpenVSafe by OpenVAERS
Search V-safe

2UW-47339-41424

3 vaccinations 1 coded response 6 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
021 / MA
Registered
2021-12-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-30
    Dose 3 — Pfizer-BioNTech
  4. 2021-12-29
    Registered in v-safe
  5. 2021-12-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  6. 2022-01-04
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  7. 2022-01-11
    Survey response — day 42, dose 3
    MedDRA: Rhinorrhoea — Feeling: Good · Be unable to work or attend school
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-03-01
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  9. 2022-06-03
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  10. 2022-11-30
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech No
22021-04-14Pfizer-BioNTech No
32021-11-30Pfizer-BioNTech No

Free text

Release 10 — day 42, dose 3

2022-01-11

Symptoms: Runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…